Patient Engagement Best Practices: The Benefits Without the Risks
Discover how to get the most out of your patient engagement programs while protecting your brand from regulatory non-compliance.
Patient Engagement Best Practices: The Benefits Without the Risks
Discover how to get the most out of your patient engagement programs while protecting your brand from regulatory non-compliance.
In this 60 minute webinar, our panelists discuss:
-
How to engage patients effectively while protecting your company from regulatory risks?
-
How to provide benefits to patients while keeping your brand safe?
-
What to overcome the challenges to patient engagement?
featured Presenter:
Jeremy Lutsky
Counsel, Manatt Health
Jeremy
Lutsky has over 20 years of deep FDA regulatory, transactional and
in-house compliance experience, including ten-plus years working
in-house with several prominent biotech and medical device companies.
With an intimate understanding of the needs and inner workings of the
pharmaceutical and medical device spaces, he provides counsel on a wide
range of legal and regulatory matters, including FDA compliance,
contracting, transactions, M&A, advertising, sponsorships and
promotional review.
Before joining Manatt, Jeremy served as senior legal and compliance
counsel for a leading biopharmaceutical manufacturing company, where he
was the primary legal contact for all regulatory and compliance matters
related to the company’s antibiotic product and co-promoted respiratory
product. He worked with internal teams across sales, marketing, finance
and HR to advise on commercial and regulatory issues ranging from
advertising and promotions, fraud and abuse laws, pricing and
reimbursement, contracting and HCP advisory boards, and consulting
relationships.
As a member of the commercial leadership team, Jeremy provided not
only legal and compliance guidance but also input on cutting-edge
initiatives such as patient assistance programs and market access. In
addition, he was relied upon to keep the team abreast of new regulatory
developments, such as the recent guidance documents on payor
communications and medical product communications that are consistent
with approved labeling.
Jeremy has deep experience developing and implementing programs that
ensure compliance with federal and state laws, including the False
Claims Act, the Anti-Kickback Statute, Pharmaceutical Research and
Manufacturers of America and Advanced Medical Technology Association
codes, the Sunshine Act, and other FDA/Office of Inspector General
guidance. He has also led the compliance function for multiple pharma
and device companies. Jeremy’s experience includes drafting and rolling
out relevant policies and procedures; conducting in-person and online
training, auditing and monitoring to ensure compliance; and conducting
investigations when necessary.
As a former senior associate for a
large national law firm and corporate counsel to a specialty
pharmaceutical and wound care company, Jeremy has also represented
hospitals, academic medical centers, health plans and other related
health systems on a variety of regulatory compliance and transactional
matters. Learn More
As a former senior associate for a large national law firm and corporate counsel to a specialty pharmaceutical and wound care company, Jeremy has also represented hospitals, academic medical centers, health plans and other related health systems on a variety of regulatory compliance and transactional matters. Learn More